Could stem cells help people with spinocerebellar ataxia?

NCT ID NCT07467733

Not yet recruiting Disease control Sponsor: Biocells Medical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether stem cells and their exosomes (tiny particles that help cells communicate) can safely improve movement in people with spinocerebellar ataxia, a condition that affects coordination and balance. Ninety participants will receive the treatment through an IV and a nasal spray. The study focuses on safety and whether it can reduce symptoms like tremors and unsteady walking.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: neuroinduced mesenchymal stem cells and exosomes
What this could lead to: If it works, this could point toward a new treatment to improve motor function and slow progression of spinocerebellar ataxia.
What could go wrong: This is an early Phase I/II trial with only 90 participants, so results may not confirm effectiveness. Risks include unknown side effects from stem cell and exosome infusions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINOCEREBELLAR ATAXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ataxia autosomal dominant cerebellar ataxia cerebellar ataxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINOCEREBELLAR ATAXIA - ALL SUB-TYPES

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

BioCells Medical

Warsaw, 02-797, Poland

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.